GH Research (GHRS) Common Equity (2021 - 2025)

GH Research's Common Equity history runs 5 years deep, the most recent figure standing at $279.7 million for Q4 2025.

• On a quarterly basis, Common Equity rose 56.3% year-over-year to $279.7 million in Q4 2025; TTM through Dec 2025 was $279.7 million, a 56.3% increase from a year earlier, with the FY2025 full-year figure at $279.7 million, up 56.3% from the prior year.
• Common Equity fell to $279.7 million in Q4 2025 per GHRS's latest filing, from $291.4 million in the prior quarter.
• Across five years, Common Equity topped out at $310.2 million in Q1 2025 and bottomed at $179.0 million in Q4 2024.
• The 5-year median for Common Equity is $253.3 million (2022), against an average of $248.9 million.
• Across the five-year window, Common Equity dropped 18.28% in 2024 and soared 56.3% in 2025, its largest moves.
• Year by year, Common Equity stood at $277.2 million in 2021, then dropped by 9.87% to $249.8 million in 2022, then declined by 12.35% to $219.0 million in 2023, then dropped by 18.28% to $179.0 million in 2024, then surged by 56.3% to $279.7 million in 2025.
• Per Business Quant, the three latest GHRS Common Equity figures stand at $279.7 million (Q4 2025), $291.4 million (Q3 2025), and $303.2 million (Q2 2025).